White paper – The future of medicine: Cell and gene therapy

Cell and gene therapy (CGT) also known as advanced therapy medicinal products (ATMPs) is the latest phenomenon in medicine that is gaining momentum. Ground-breaking treatments that are shifting the healthcare paradigm from one of illness management to cure are constantly grabbing headlines globally. With this, in recent years we have seen a flurry of attention from investors, regulators, pharmaceuticals and the wider life sciences industry.

Download a copy: White paper – The future of medicine: Cell and gene therapy